Annual FCF
-$21.66 M
+$18.11 M+45.53%
31 December 2023
Summary:
NRx Pharmaceuticals annual free cash flow is currently -$21.66 million, with the most recent change of +$18.11 million (+45.53%) on 31 December 2023. During the last 3 years, it has fallen by -$19.39 million (-855.45%). NRXPW annual FCF is now -2632.33% below its all-time high of -$792.73 thousand, reached on 31 December 2019.NRXPW Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
-$2.31 M
+$256.00 K+9.99%
30 September 2024
Summary:
NRx Pharmaceuticals quarterly free cash flow is currently -$2.31 million, with the most recent change of +$256.00 thousand (+9.99%) on 30 September 2024. Over the past year, it has increased by +$2.26 million (+49.50%). NRXPW quarterly FCF is now -108.73% below its all-time high of $26.40 million, reached on 31 December 2021.NRXPW Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
-$11.73 M
+$2.26 M+16.15%
30 September 2024
Summary:
NRx Pharmaceuticals TTM free cash flow is currently -$11.73 million, with the most recent change of +$2.26 million (+16.15%) on 30 September 2024. Over the past year, it has dropped by -$7.16 million (-156.90%). NRXPW TTM FCF is now -203.33% below its all-time high of $11.35 million, reached on 31 December 2021.NRXPW TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NRXPW Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +45.5% | +49.5% | -156.9% |
| 3 y3 years | -855.5% | +80.8% | +23.5% |
| 5 y5 years | - | -4308.0% | -2110.5% |
NRXPW Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -855.5% | +45.5% | -108.7% | +84.4% | -203.3% | +23.5% |
| 5 y | 5 years | -2632.3% | +45.5% | -108.7% | +84.4% | -203.3% | +23.5% |
| alltime | all time | -2632.3% | +45.5% | -108.7% | +84.4% | -203.3% | +23.5% |
NRx Pharmaceuticals Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$2.31 M(-10.0%) | -$11.73 M(-16.2%) |
| June 2024 | - | -$2.56 M(-30.2%) | -$13.99 M(+22.4%) |
| Mar 2024 | - | -$3.67 M(+15.0%) | -$11.43 M(+47.3%) |
| Dec 2023 | -$21.66 M(-45.5%) | -$3.19 M(-30.1%) | -$7.76 M(+69.9%) |
| Sept 2023 | - | -$4.57 M(-69.1%) | -$4.57 M(-57.7%) |
| Dec 2022 | -$39.77 M(+5.4%) | - | - |
| June 2022 | - | -$14.79 M(+42.5%) | -$10.80 M(-371.0%) |
| Mar 2022 | - | -$10.38 M(-139.3%) | $3.98 M(-64.9%) |
| Dec 2021 | -$37.71 M | $26.40 M(-319.7%) | $11.35 M(-174.0%) |
| Sept 2021 | - | -$12.02 M(>+9900.0%) | -$15.34 M(+244.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2021 | - | -$14.41 K(-99.5%) | -$4.45 M(-4.6%) |
| Mar 2021 | - | -$3.02 M(+933.5%) | -$4.67 M(+170.0%) |
| Dec 2020 | -$2.27 M(+186.0%) | -$291.73 K(-74.2%) | -$1.73 M(+1.7%) |
| Sept 2020 | - | -$1.13 M(+390.3%) | -$1.70 M(+173.5%) |
| June 2020 | - | -$230.46 K(+201.5%) | -$621.28 K(+8.7%) |
| Mar 2020 | - | -$76.43 K(-70.8%) | -$571.47 K(-27.9%) |
| Dec 2019 | -$792.73 K | -$262.07 K(+401.0%) | -$792.73 K(+49.4%) |
| Sept 2019 | - | -$52.31 K(-71.0%) | -$530.66 K(+10.9%) |
| June 2019 | - | -$180.65 K(-39.3%) | -$478.34 K(+60.7%) |
| Mar 2019 | - | -$297.70 K | -$297.70 K |
FAQ
- What is NRx Pharmaceuticals annual free cash flow?
- What is the all time high annual FCF for NRx Pharmaceuticals?
- What is NRx Pharmaceuticals annual FCF year-on-year change?
- What is NRx Pharmaceuticals quarterly free cash flow?
- What is the all time high quarterly FCF for NRx Pharmaceuticals?
- What is NRx Pharmaceuticals quarterly FCF year-on-year change?
- What is NRx Pharmaceuticals TTM free cash flow?
- What is the all time high TTM FCF for NRx Pharmaceuticals?
- What is NRx Pharmaceuticals TTM FCF year-on-year change?
What is NRx Pharmaceuticals annual free cash flow?
The current annual FCF of NRXPW is -$21.66 M
What is the all time high annual FCF for NRx Pharmaceuticals?
NRx Pharmaceuticals all-time high annual free cash flow is -$792.73 K
What is NRx Pharmaceuticals annual FCF year-on-year change?
Over the past year, NRXPW annual free cash flow has changed by +$18.11 M (+45.53%)
What is NRx Pharmaceuticals quarterly free cash flow?
The current quarterly FCF of NRXPW is -$2.31 M
What is the all time high quarterly FCF for NRx Pharmaceuticals?
NRx Pharmaceuticals all-time high quarterly free cash flow is $26.40 M
What is NRx Pharmaceuticals quarterly FCF year-on-year change?
Over the past year, NRXPW quarterly free cash flow has changed by +$2.26 M (+49.50%)
What is NRx Pharmaceuticals TTM free cash flow?
The current TTM FCF of NRXPW is -$11.73 M
What is the all time high TTM FCF for NRx Pharmaceuticals?
NRx Pharmaceuticals all-time high TTM free cash flow is $11.35 M
What is NRx Pharmaceuticals TTM FCF year-on-year change?
Over the past year, NRXPW TTM free cash flow has changed by -$7.16 M (-156.90%)